In today’s session Perrigo Company plc Ordinary Shares (PRGO) recorded an unusually high (716) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the November, 2016 put, expecting serious PRGO decrease. With 716 contracts traded and 19294 open interest for the Nov, 16 contract, it seems this is a quite bearish bet. The option with symbol: PRGO161118P00085000 closed last at: $3.9 or 59.2% up. About 543,020 shares traded hands. Perrigo Company plc Ordinary Shares (NYSE:PRGO) has declined 35.82% since March 30, 2016 and is downtrending. It has underperformed by 38.83% the S&P500.
Perrigo Company plc Ordinary Shares (NYSE:PRGO) Ratings Coverage
Out of 14 analysts covering Perrigo Company Plc (NYSE:PRGO), 4 rate it a “Buy”, 1 “Sell”, while 9 “Hold”. This means 29% are positive. Perrigo Company Plc has been the topic of 33 analyst reports since October 23, 2015 according to StockzIntelligence Inc. JP Morgan maintained the stock with “Neutral” rating in Tuesday, April 26 report. Deutsche Bank maintained Perrigo Company plc Ordinary Shares (NYSE:PRGO) rating on Friday, October 23. Deutsche Bank has “Buy” rating and $187 price target. Barclays Capital maintained the shares of PRGO in a report on Thursday, August 11 with “Overweight” rating. Goldman Sachs downgraded it to “Sell” rating and $124 target price in Monday, February 22 report. Jefferies maintained Perrigo Company plc Ordinary Shares (NYSE:PRGO) rating on Thursday, August 11. Jefferies has “Hold” rating and $84 price target. On Monday, April 25 the stock rating was downgraded by Wells Fargo to “Market Perform”. The firm has “Hold” rating given on Monday, April 25 by Stifel Nicolaus. The rating was initiated by Morgan Stanley on Thursday, December 3 with “Equal-Weight”. The rating was maintained by Barclays Capital on Tuesday, April 26 with “Overweight”. Barclays Capital initiated Perrigo Company plc Ordinary Shares (NYSE:PRGO) rating on Thursday, January 21. Barclays Capital has “Overweight” rating and $180 price target.
According to Zacks Investment Research, “Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.”
Insitutional Activity: The institutional sentiment decreased to 0.81 in 2016 Q2. Its down 0.38, from 1.19 in 2016Q1. The ratio fall, as 103 funds sold all Perrigo Company plc Ordinary Shares shares owned while 175 reduced positions. 80 funds bought stakes while 146 increased positions. They now own 96.70 million shares or 9.76% less from 107.16 million shares in 2016Q1.
Raymond James Advsr Inc has invested 0.01% of its portfolio in Perrigo Company plc Ordinary Shares (NYSE:PRGO). Advantus accumulated 13,908 shares or 0.04% of the stock. Fayerweather Charles accumulated 3,659 shares or 0.46% of the stock. Moreover, Kidder Stephen W has 0.24% invested in Perrigo Company plc Ordinary Shares (NYSE:PRGO) for 6,710 shares. Glenmede Tru Na has invested 0% of its portfolio in Perrigo Company plc Ordinary Shares (NYSE:PRGO). Envestnet Asset Management Incorporated, a Illinois-based fund reported 27,625 shares. Ontario Teachers Pension Plan Board has 0.66% invested in the company for 655,000 shares. Tiaa Cref Management Lc holds 477,867 shares or 0.03% of its portfolio. Broderick Brian C reported 6,726 shares or 0.26% of all its holdings. Cornerstone Capital Mgmt Lc has invested 2.62% of its portfolio in Perrigo Company plc Ordinary Shares (NYSE:PRGO). Royal Financial Bank Of Canada last reported 94,448 shares in the company. Putnam Invs Ltd Limited Liability Company accumulated 0.05% or 222,600 shares. Fmr Ltd Com holds 561,061 shares or 0.01% of its portfolio. Bb&T Corp owns 58,191 shares or 0.11% of their US portfolio. Meeder Asset Mgmt Inc has 7 shares for 0% of their US portfolio.
PRGO Company Profile
Perrigo Company plc (Perrigo), formerly Perrigo Company Limited, incorporated on June 28, 2013, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company’s divisions include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences and Other. The Firm makes OTC healthcare products and supplies infant formulas for the store brand market. It is also a well-known provider of generic extended topical prescription products. It provides healthcare products across a range of product categories and geographies, primarily in North America, Europe and Australia, as well as in other markets, including Israel and China.
More important recent Perrigo Company plc Ordinary Shares (NYSE:PRGO) news were published by: Fool.com which released: “Why Perrigo Company PLC Ordinary Shares Are Dropping Today” on April 25, 2016, also Fool.com published article titled: “Why Perrigo Company PLC Ordinary Shares Are Plummeting Today”, Investorplace.com published: “3 Stocks to Watch Monday: Tesla Motors Inc (TSLA), Perrigo Company plc …” on September 12, 2016. More interesting news about Perrigo Company plc Ordinary Shares (NYSE:PRGO) was released by: Investorplace.com and their article: “Why KLA-Tencor Corp (KLAC), Perrigo Company plc Ordinary Shares (PRGO) and …” with publication date: August 10, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.